Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for 908 Devices Inc. (MASS:NASDAQ), powered by AI.
908 Devices Inc. is currently trading at $8.64. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for 908 Devices Inc. on Alpha Lenz.
View 908 Devices Inc.'s valuation metrics on Alpha Lenz.
“908 Devices Inc.'s ROE is 15.1%. Explore profitability and growth together.”
Ask for details →908 Devices Inc. is a cutting-edge biotechnology firm specializing in the design and development of innovative chemical analysis devices. The primary mission of 908 Devices Inc. is to deliver straightforward, portable analytical tools that enhance chemical and biochemical analysis processes across various sectors. Their suite of devices includes handheld, desktop, and small-scale instruments that facilitate real-time, point-of-need analytics, empowering end-users in industries such as life sciences, pharmaceuticals, and public safety. These devices are crucial in applications like drug development, environmental monitoring, and forensic investigation, offering precision and ease of access. With a commitment to advancing technology and miniaturizing complex instrumentation, 908 Devices Inc. significantly contributes to increasing efficiency and accuracy in analytical methodologies, thereby supporting vital decision-making processes in diverse fields. By merging engineering excellence with scientific insight, this company plays an essential role in pushing the boundaries of traditional laboratory-based analysis, bringing sophisticated solutions to everyday use cases in the market.
“908 Devices Inc.'s ROE is 15.1%. Explore profitability and growth together.”
Ask for details →908 Devices Inc. (ticker: MASS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 246 employees.
The current price is $8.64 with a P/E ratio of -x and P/B of -x.
ROE is 15.09% and operating margin is -45.70%. Annual revenue is $56M.